We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$27.9M
BBA
2
Baker Bros. Advisors
New York
$23.7M
BlackRock
3
BlackRock
New York
$21.6M -$1.79M -9,857 -7%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$21.2M +$737K +4,057 +3%
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$18.8M
PAMU
6
Pictet Asset Management (UK)
United Kingdom
$17.6M +$97.9K +539 +0.5%
Vanguard Group
7
Vanguard Group
Pennsylvania
$14.6M -$559K -3,075 -4%
SCM
8
Suvretta Capital Management
New York
$14.6M +$5.28M +29,081 +53%
ACM
9
Aisling Capital Management
New York
$11.8M
NCM
10
Nantahala Capital Management
Connecticut
$11.7M -$255K -1,403 -2%
RSCM
11
Rock Springs Capital Management
Maryland
$11M
Goldman Sachs
12
Goldman Sachs
New York
$7.87M -$40.9K -225 -0.5%
AG
13
Artal Group
Luxembourg
$7.27M
GPP
14
Great Point Partners
Connecticut
$6.26M +$2.89M +15,884 +79%
SB
15
Samsara BioCapital
California
$6.15M
State Street
16
State Street
Massachusetts
$5.27M +$284K +1,561 +5%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.72M +$144K +794 +3%
Marshall Wace
18
Marshall Wace
United Kingdom
$4.53M -$3.92M -21,594 -45%
ACM
19
Altium Capital Management
New York
$4.24M +$2.49M +13,678 +128%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$4.21M +$77.6K +427 +2%
BC
21
Boxer Capital
California
$3.83M
Millennium Management
22
Millennium Management
New York
$3.78M +$1.25M +6,882 +46%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$3.27M -$7.49M -41,209 -69%
Axa
24
Axa
France
$2.95M +$3.09K +17 +0.1%
SCM
25
Sio Capital Management
New York
$2.8M